February 24, 2012
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on New Drugs approved orphan drug designation for three drugs including Novartis Pharma’s imatinib mesylate (expected indication: pulmonary arterial hypertension) as orphan drugs on February 24. Pulmonary arterial hypertension (PAH)...read more